Created in 2015, the Maculart International Meeting has established itself as a key international event dedicated to macular diseases.
In 2027, Maculart will once again bring together world-leading experts to present and discuss major advances in retinal imaging, innovative therapies, macular surgery, artificial intelligence and personalized medicine. As a high-level scientific platform, the meeting fosters international collaboration, clinical innovation, and the dissemination of best practices.
At the intersection of science, technology, and clinical expertise, Maculart 2027 will deliver a scientific program focused on current challenges and future perspectives in the management of macular diseases.
A must-attend event for all stakeholders committed to innovation and excellence in ophthalmology.
Highlights of the Maculart International Meeting 2027
- Artificial Intelligence: exploring the growing role of AI in retinal imaging, diagnosis, disease monitoring and clinical decision-making.
- Innovative Imaging: discovering the latest developments in retinal imaging and the new perspectives they offer for understanding and managing macular diseases.
- Innovative Treatments: discussing emerging therapeutic strategies and the latest advances transforming the management of macular diseases.
- AMD, Geographic Atrophy and Prevention: addressing current challenges and future perspectives in age-related macular degeneration, with a particular focus on geographic atrophy and prevention.
- Diabetes and Vascular Disorders: exploring advances in the diagnosis and management of diabetic and vascular macular diseases.
- Myopia and Surgery: examining the evolving challenges and innovative approaches associated with myopia and macular surgery.
- Out of the Box: opening the discussion to emerging ideas, unconventional perspectives and innovative concepts beyond established boundaries.
Registration is open!
CALL FOR FREE PAPERS, CLINICAL CASES AND GABRIEL COSCAS AWARD IS NOW OPEN! – Deadline for Abstract Submissions : February 1, 2027
For more information, please visit : www.maculart.fr
Contact : maculart@europa-organisation.com
